Medication info
Ducanova Tablet 60/5 mg (Fimasartan, Esamlodipine)

Ducanova Tablet 60/5 mg (Fimasartan, Esamlodipine)

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›66.01mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›7.48mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Orange-colored, rounded square film-coated tablet
Packaging
30 tablets / bottle, 300 tablets / bottle
Approval status
Active

MFDS item code 202300096 · Approved 2023.01.06 · Insurance code 694003940

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is necessary for elderly patients 70 years of age or younger. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine in pediatric and adolescent patients 18 years of age or younger have not been established.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

This medication is used to assist in effective blood pressure control in patients with essential hypertension who are not adequately controlled on Fimasartan Potassium monotherapy.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dosage adjustment is necessary for elderly patients 70 years of age or younger. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 milligrams in this medicine. Patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine in pediatric and adolescent patients 18 years of age or younger have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn in the second and third trimesters of pregnancy; it should be discontinued immediately upon confirmation of pregnancy. It is contraindicated in patients with allergies to the active ingredients or similar components, in pregnant or breastfeeding women, in patients undergoing renal dialysis, in patients with severe liver impairment, and in patients with bile duct obstruction. Patients with low blood volume or low salt levels, impaired kidney function, renal artery hypertension, aortic stenosis or mitral stenosis, and the elderly should use this drug with caution and be closely monitored. Side effects such as dizziness, headache, facial or peripheral edema, urinary disturbances, insomnia, and flushing may occur; if symptoms are severe, consult a physician. Hypotension may occur, requiring the patient to lie down and administer fluids if blood pressure drops too low. This medication may increase serum potassium levels; therefore, patients with heart failure or renal disease should regularly check their potassium levels through blood tests. Interactions may occur when used with other antihypertensives, potassium-sparing diuretics, certain anti-inflammatory medications, and lithium. Always inform healthcare providers of other medications being taken. Use during pregnancy carries a risk of serious abnormalities to the fetus, so this medication should be avoided if planning to become pregnant or if currently pregnant. If breastfeeding, it is recommended to discontinue breastfeeding or this medication due to the possibility of excretion into breast milk. Safety in children and adolescents has not been established; it is advised not to use this medication in these populations. Overdose may result in hypotension, cardiac arrhythmias, and severe vasodilation. Care should be taken not to exceed the recommended dosage, and in case of overdose, consult healthcare providers immediately. This medication should be kept out of reach of children, and transferring to another container may compromise quality.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urinary disorder
  • insomnia
  • flushing
  • syncope
  • sedation
Show 123 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • pruritus
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • exacerbation of low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • hypertension
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • weakness
  • fatigue
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • increased tension
  • sensory impairment
  • paresthesia
  • peripheral neuropathy
  • taste disturbance
  • tremor
  • extrapyramidal disorder
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • dyspepsia
  • gingival hyperplasia
  • pancreatitis
  • sweating
  • hair loss
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • substernal pain
  • diarrhea
  • loose stools
  • constipation
  • skin erythematous rash
  • maculopapular rash
  • heaviness
  • heat sensation
  • decreased glucose tolerance
  • frailty

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light; it should be stored in a container that does not allow light. Additionally, it should be stored at room temperature between 1°C and 30°C for safe use.

Appearance and packaging

Appearance

Orange-colored, rounded square film-coated tablet

Package unit

30 tablets / bottle, 300 tablets / bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.